TY - JOUR
T1 - Immunizations in children on PD
T2 - current guidelines and recommendations.
AU - Fivush, B. A.
AU - Furth, S. L.
AU - Neu, A. M.
PY - 1995
Y1 - 1995
N2 - Antibody responses to currently recommended immunizations in pediatric patients on chronic peritoneal dialysis (CPD) have been measured and the results have been variable. Although the incidence of vaccine-preventable disease in pediatric CPD patients is not known, it appears that protection from these diseases may be reduced. The explanation for the abnormal response to vaccines might include lower seroconversion rates in these patients, with lower antibody titers or levels. Also a rapid decline of antibody levels or titers may occur as a consequence of continuous peritoneal dialysis. Specific vaccines that may result in a less than optimal response in pediatric CPD patients include hepatitis B virus, hemophilus influenza type b, measles, mumps, rubella and pneumococcal vaccine. Patients who receive these immunizations should be monitored closely. Increased vaccine dosage, reinforced vaccination schedules, as well as concomitantly administered adjuvant immuno-modulators may play an important role in more effective vaccination of pediatric CPD patients. It is important that vaccine response be monitored in these patients by measuring specific antibody titers or levels to ensure adequate protection from vaccine-preventable illness.
AB - Antibody responses to currently recommended immunizations in pediatric patients on chronic peritoneal dialysis (CPD) have been measured and the results have been variable. Although the incidence of vaccine-preventable disease in pediatric CPD patients is not known, it appears that protection from these diseases may be reduced. The explanation for the abnormal response to vaccines might include lower seroconversion rates in these patients, with lower antibody titers or levels. Also a rapid decline of antibody levels or titers may occur as a consequence of continuous peritoneal dialysis. Specific vaccines that may result in a less than optimal response in pediatric CPD patients include hepatitis B virus, hemophilus influenza type b, measles, mumps, rubella and pneumococcal vaccine. Patients who receive these immunizations should be monitored closely. Increased vaccine dosage, reinforced vaccination schedules, as well as concomitantly administered adjuvant immuno-modulators may play an important role in more effective vaccination of pediatric CPD patients. It is important that vaccine response be monitored in these patients by measuring specific antibody titers or levels to ensure adequate protection from vaccine-preventable illness.
UR - http://www.scopus.com/inward/record.url?scp=0029442567&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029442567&partnerID=8YFLogxK
M3 - Article
C2 - 8534720
AN - SCOPUS:0029442567
SN - 1197-8554
VL - 11
SP - 270
EP - 273
JO - Advances in peritoneal dialysis. Conference on Peritoneal Dialysis
JF - Advances in peritoneal dialysis. Conference on Peritoneal Dialysis
ER -